May 24, 2025

The business lovers

Joseph B. Hash

Atos establishes Life Sciences Centre of Excellence to support researchers worldwide

London, United kingdom Paris, France – July 8 2020

Atos, a international leader in digital transformation, in settlement with the Wellcome Genome Campus, in Cambridgeshire, United kingdom, today announces its international HPC, AI & Quantum Existence Sciences Centre of Excellence in order to offer organisations on Campus, and international genome and bio-data institutes globally, accessibility to emerging HPC, AI & Quantum technologies.

The Atos Existence Sciences Centre of Excellence will complement the existing Campus compute services with accessibility to top-edge technologies, this sort of as Quantum, Higher General performance Computing and AI, supported by Atos’ products and solutions, companies and know-how in these sectors. Atos specialists will collaborate instantly with genome and organic data analysis experts to assist boost Existence Sciences discovery and innovation.

“I am delighted that Atos is joining our Campus community, providing larger perception into biodata at exceptional speeds and efficacy will guide to revolutionary new methodologies and products and solutions, as well as lessening the analysis-to-merchandise development journey generating a substantial positive affect for the a variety of locations of everyday living sciences”, mentioned Dr Julia Wilson, Affiliate Director, Wellcome Genome Campus.

 “With substantial development options in position Atos will swiftly become a useful partner in our Campus community. Now is the time to power our analysis by means of the utilized use of revolutionary technologies that could tremendously advance biodata analysis. This will guide to larger alternatives to translate analysis into tangible societal benefits”, added Dr Jo Mills, Entrepreneurship and Innovation Centre Supervisor, Wellcome Genome Campus.

In this Centre, researchers and technologists globally will discover the diverse usages of technologies this sort of as Quantum, Higher General performance Computing and AI by means of a wide assortment of routines this sort of as proof of notion creation, innovation workshops, classes and conferences.

Atos Quantum Mastering Device, the world’s maximum-executing commercially accessible quantum simulator, is already aiding the analysis evaluation ability of organizations together with Bayer in Germany, the Centre of Computation  Research and Technologies (CCRT) at the CEA in France, The Hartree Centre in United kingdom and Oak Ridge National Laboratory in the US.

Scientists will also be capable to advantage from Atos’ effective BullSequana X supercomputers, which produce high-effectiveness computing power to support researchers realize effects quicker. They are currently being employed today throughout the globe to support the existing combat from Covid-19.

Pierre Barnabé, Senior Executive Vice-President, Head of Large Data & Cybersecurity at Atos, mentioned: “We are delighted to create the Centre, as the prospective for collaborative chance with Existence Sciences institutes globally is huge. Quantum, Higher General performance Computing as well as edge computing assisted by synthetic intelligence maintain interesting, transformative prospective for the everyday living sciences sector, and we are searching forward to making use of these in actual globe situations by combining analysis know-how with our technological know-how to unlock chance.”

The Centre is already running remotely and is supplying support to researchers globally studying many diverse areas of Covid-19 this sort of as characterizing the construction of SARS-CoV-two to much better comprehend its mechanisms of infection or modelling the spread of the condition by working with mathematical methods.

Also, two demos are currently being designed which unlock the value of HPC and AI to product cardiovascular anomalies and to accelerate the interpretation of professional medical processes. These will be showcased as quickly as the Centre opens its doorways.